Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04118868 |
| Title | Pembrolizumab Administered Via the Sofusa DoseConnect™ in Patients With Relapsed/Refractory Cutaneous T-cell Lymphoma. |
| Recruitment | Unknown status |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Sorrento Therapeutics, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| City of Hope | RECRUITING | Duarte | California | 91010 | United States | Details |